Travere Therapeutics Cash Flow Statement (2011-2026) | TVTX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Feb2011 Aug2011 Nov2011 May2012 Aug2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-39.01M-35.64M-88.77M5.78M12.99M14.41M19.81M10.23M16.30M239.98M-1.58M-0.10M-0.76M-0.06M0.00M24.71M-0.50M
Share-based Compensation (Quarter)
7.30M6.99M7.38M8.19M12.64M8.02M9.30M13.47M11.31M11.32M8.14M9.76M9.92M8.02M9.21M11.49M10.65M11.26M11.46M16.15M
Deferred Taxes (Quarter)
Cash from Discontinued Operations (Quarter)
22.06M17.53M18.61M15.29M-6.10M-0.10M-0.31M0.05M-7.09M
Gains from Investment Securities (Quarter)
1.50M13.90M5.03M9.08M4.91M3.18M6.37M1.10M1.84M3.09M-2.19M0.04M0.08M-0.15M1.56M-0.04M0.00M
Asset Writedowns and Impairment (Quarter)
0.47M0.41M-0.87M0.95M0.79M0.33M-1.03M
Cash from Operations (Quarter)
6.50M32.06M-88.32M-55.32M-36.81M-92.02M-76.70M-98.65M-51.77M-110.57M-64.37M-118.90M-40.35M-42.51M-28.27M-42.19M4.98M14.32M60.68M-40.37M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.48M-0.65M-0.70M-0.67M-0.22M0.57M1.02M1.85M2.27M
Amortization of Deferred Charges (Quarter)
0.23M0.23M2.89M0.34M0.43M0.43M0.43M
Depreciation & Amortization (CF) (Quarter)
6.62M7.87M-7.82M7.09M8.11M-0.79M6.31M6.62M10.95M11.47M9.49M9.88M10.35M11.24M12.09M12.80M14.02M15.79M18.14M25.21M
Change in Working Capital
Change in Receivables (Quarter)
-1.21M1.48M1.72M-1.24M2.02M-5.72M6.00M4.66M-0.58M-0.79M7.97M1.55M1.74M0.73M1.98M7.20M4.28M44.16M-27.82M7.22M
Change in Inventory (Quarter)
0.70M-0.38M-0.50M0.16M1.90M-0.81M-0.04M0.51M11.75M4.77M22.39M1.82M1.42M0.25M0.28M-3.66M0.02M-0.19M-1.18M0.74M
Change in Accured Expenses (Quarter)
5.35M-9.64M5.45M-1.89M10.96M-9.27M-1.41M-0.24M-0.74M-0.24M23.54M-24.84M9.20M-2.93M1.01M0.71M-5.93M-1.11M6.25M1.94M
Change in Taxes (Quarter)
-16.77M0.01M-0.09M0.26M-0.02M
Other Working Capital Changes (Quarter)
0.74M0.82M36.26M-2.15M4.48M-11.23M-4.03M2.60M-9.42M-3.38M-5.58M-1.52M3.38M3.04M-11.02M1.67M-4.49M
Investing Activities
Capital Expenditures (Quarter)
0.10M0.35M0.15M0.13M0.02M0.01M0.03M0.63M0.00M0.01M0.03M0.08M0.14M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
4.20M5.03M5.05M5.14M11.44M7.62M4.17M23.00M0.50M1.10M5.50M6.47M4.10M5.40M9.64M11.78M11.40M15.60M19.24M22.18M
Acquisitions (Quarter)
Divestments (Quarter)
1.23M
Change in Acquisitions & Divestments (Quarter)
89.67M134.03M57.51M64.72M152.61M112.29M52.38M94.12M102.75M87.70M50.00M111.36M105.60M54.32M55.05M53.16M81.40M106.62M82.42M48.78M
Cash from Investing Activities (Quarter)
-71.81M32.52M7.37M33.16M-39.10M10.08M-36.70M-37.04M-23.55M133.32M-224.35M104.90M28.61M46.13M-80.31M41.29M4.85M86.59M-104.84M21.55M
Financing Activities
Other financing activities (Quarter)
-6.10M9.49M0.39M-12.36M-0.60M-0.26M-0.26M-0.26M
Cash from Financing Activities (Quarter)
0.30M2.41M39.32M113.91M0.83M4.15M1.16M217.00M3.13M-1.50M0.12M-0.53M0.78M0.05M139.12M3.72M1.48M-65.34M26.68M4.20M
Additional items
Exchange Rate Effect (Quarter)
0.06M0.04M1.72M-0.94M-1.74M-1.25M1.14M0.85M0.08M-0.18M1.23M-0.29M-0.11M0.45M-0.96M0.55M1.95M0.21M-0.41M-0.06M
Change in Cash (Quarter)
-64.94M67.04M15.43M90.82M-76.81M-28.42M-89.65M99.69M-90.50M73.37M-86.07M-14.93M-10.96M4.12M22.13M3.36M13.26M35.78M-17.89M-14.67M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)
6.39M31.71M-88.48M-55.45M-36.82M-92.03M-76.73M-99.28M-51.77M-110.58M-64.40M-118.90M-40.43M-42.51M-28.27M-42.19M4.98M14.18M60.68M-40.37M
Net Cash Flow (Quarter)
-65.01M67.00M-41.64M91.76M-75.07M-77.78M-112.25M81.31M-72.19M21.25M-288.60M-14.53M-10.95M3.67M30.54M2.81M11.31M35.57M-17.48M-14.61M